This Article Full Text Full Text (PDF) All Versions of this Article: 106/7/831    most recent 01.CIR.0000025631.68522.9Dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bengel, F. M. Articles by Schwaiger, M. Search for Related Content PubMed PubMed Citation Articles by Bengel, F. M. Articles by Schwaiger, M. Related Collections Nuclear cardiology and PET CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2002;106:831.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Clinical Determinants of Ventricular Sympathetic Reinnervation After Orthotopic Heart Transplantation

Frank M. Bengel, MD; Peter Ueberfuhr, MD; Thomas Hesse, MS; Nina Schiepel, MS; Sibylle I. Ziegler, PhD; Siegfried Scholz, MD; Stephan G. Nekolla, PhD; Bruno Reichart, MD; Markus Schwaiger, MD

From Nuklearmedizinische Klinik und Poliklinik der Technischen Universität (F.M.B., T.H., N.S., S.I.Z., S.G.N., M.S.), Herzchirurgische Klinik der Ludwig-Maximilians-Universität (P.U., B.R.), and Labor für Immungenetik der Ludwig-Maximilians-Universität (S.S.), Munich, Germany.

Correspondence to Frank M. Bengel, MD, Nuklearmedizinische Klinik und Poliklinik, Technische Universität München, Klinikum rechts der Isar, Ismaninger Straße 22, 81675 München, Germany. E-mail frank.bengel{at}lrz.tu-muenchen.de

Background— It has been demonstrated that ventricular sympathetic reinnervation after cardiac transplantation improves exercise performance. The extent of reinnervation increases with time but is variable. Little is known about other influencing factors.

Methods and Results— Seventy-seven nonrejecting transplant recipients were cross-sectionally studied by PET with the catecholamine analogue C-11 hydroxyephedrine at 4.8±3.5 years after transplantation. Results were compared with history-derived parameters related to recipient’s clinical course before, during, and after surgery; donor characteristics; and immunogenetics. Partial reinnervation was observed in 52 patients (extent, 21±16% of left ventricle). Complete denervation was found in 25 patients at various times after transplantation. Reinnervation extent correlated with time after surgery (r=0.387; P<0.001) but also inversely with donor age (r=-0.309, P=0.006) and recipient age (r=-0.243, P=0.032). Maximal hydroxyephedrine retention correlated inversely with frequency of rejection episodes (r=-0.267, P=0.019), was reduced when aortic complications occurred perioperatively (9 patients), and correlated inversely with aortic cross-clamp time (r=-0.331, P=0.006). Other parameters were not associated with reinnervation. Patients were surveyed for clinical complications over >12 months after PET (until 7.3±4.2 years after transplantation), but significant effects of reinnervation on outcome were not observed.

Conclusions— The present data suggest that sympathetic reinnervation after cardiac transplantation is not simply a function of time. Reinnervation is more likely with young age, fast and uncomplicated surgery, and low rejection frequency. Despite few effects on prognosis in otherwise healthy recipients, improved understanding of clinical determinants may contribute to enhance allograft reinnervation and thereby augment exercise capacity in the future.

Key Words: nervous system, sympathetic • transplantation • tomography

This article has been cited by other articles:

				S. B. Marko and D. H. Damon VEGF promotes vascular sympathetic innervation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2646 - H2652. [Abstract] [Full Text] [PDF]

				F. M. Bengel, P. Ueberfuhr, D. Schafer, S. G. Nekolla, B. Reichart, and M. Schwaiger Effect of Diabetes Mellitus on Sympathetic Neuronal Regeneration Studied in the Model of Transplant Reinnervation J. Nucl. Med., September 1, 2006; 47(9): 1413 - 1419. [Abstract] [Full Text] [PDF]

				A. J. Luisi Jr., G. Suzuki, R. deKemp, M. S. Haka, S. A. Toorongian, J. M. Canty Jr., and J. A. Fallavollita Regional 11C-Hydroxyephedrine Retention in Hibernating Myocardium: Chronic Inhomogeneity of Sympathetic Innervation in the Absence of Infarction J. Nucl. Med., August 1, 2005; 46(8): 1368 - 1374. [Abstract] [Full Text] [PDF]

				F. M. Bengel, P. Ueberfuhr, J. Karja, K. Schreiber, S. G. Nekolla, B. Reichart, and M. Schwaiger Sympathetic reinnervation, exercise performance and effects of {beta}-adrenergic blockade in cardiac transplant recipients Eur. Heart J., October 1, 2004; 25(19): 1726 - 1733. [Abstract] [Full Text] [PDF]

				S. S. Lovric, V. Avbelj, R. Trobec, D. Zorman, P. Rakovec, S. Hojker, B. Gersak, and M. Milcinski Sympathetic reinnervation after heart transplantation, assessed by iodine-123 metaiodobenzylguanidine imaging, and heart rate variability Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 736 - 741. [Abstract] [Full Text] [PDF]